This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

Carnobacterium maltaromaticum: NCBI 2751, [species]

Back to details

| ATCC 27865| ATCC 35586 [[Carnobacterium piscicola]]| Carnibacterium piscicola| Carnobacterium maltaromaticum| Carnobacterium maltaromaticum (Miller et al. 1974) Mora et al. 2003| Carnobacterium maltaromicus| Carnobacterium piscicola| Carnobacterium piscicola (Hiu et al. 1984) Collins et al. 1987| CCUG 30142| CIP 103135| DSM 20342| DSM 20722 [[Lactobacillus carnis Shaw and Harding 1986]]| DSM 20730| JCM 1154| JCM 5348 [[Carnobacterium piscicola]]| JCM 9135 [[Lactobacillus carnis Shaw and Harding 1986]]| Lactobacillus carnis| Lactobacillus carnis Shaw and Harding 1986| Lactobacillus maltaromicus| Lactobacillus maltaromicus Miller et al. 1974 (Approved Lists 1980)| Lactobacillus piscicola| Lactobacillus piscicola Hiu et al. 1984| LMG 6903| LMG 9839 [[Carnobacterium piscicola]]| LMG 9840 [[Lactobacillus carnis Shaw and Harding 1986]]| LMG:6903| LMG:9839 [[Carnobacterium piscicola]]| LMG:9840 [[Lactobacillus carnis Shaw and Harding 1986]]| NBRC 15684 [[Carnobacterium piscicola]]| NCDO 2762 [[Carnobacterium piscicola]]| NCIMB 2264 [[Carnobacterium piscicola]]| NRRL B-14829 [[Carnobacterium piscicola]]| NRRL B-14852| strain LV 61 [[Lactobacillus carnis Shaw and Harding 1986]]| strain LV61 [[Lactobacillus carnis Shaw and Harding 1986]]

  1. Antibiotic Production: Streptomyces lincolnensis produces lincomycin, a lincosamide antibiotic. Lincomycin is effective against a wide range of Gram-positive bacteria, including staphylococci, streptococci, and anaerobic bacteria. It is used clinically to treat various infections, including skin and soft tissue infections, respiratory tract infections, and infections caused by anaerobic bacteria.

  2. Clinical Applications: Lincomycin, produced by Streptomyces lincolnensis, has been used clinically for many years to treat bacterial infections in humans and animals. However, its use is now more limited due to the availability of other antibiotics and concerns about antibiotic resistance and side effects.

  3. Antibiotic Resistance Studies: Streptomyces lincolnensis and its antibiotic, lincomycin, have been studied in the context of antibiotic resistance. Understanding the mechanisms of action and resistance to lincomycin can provide insights into combating antibiotic resistance in bacteria.

  4. Biotechnological Applications: Lincomycin and its derivatives may have various biotechnological applications beyond medicine. They may be used in agriculture as growth promoters for livestock or in industry for the production of semi-synthetic antibiotics.

  5. Environmental Health: Streptomyces lincolnensis, like other Streptomyces species, plays roles in soil ecology and nutrient cycling, which indirectly impact human health through ecosystem services such as soil fertility and environmental sustainability.

Other Sources for more information:

Legend

Carnobacterium maltaromaticum impacts on other bacteria of the same rank

R2SlopeTax NameParent Chart
0.349786996841430660.7245675325393677Carnobacterium divergensParent Taxa
0.121153451502323150.3047938644886017Lactococcus pisciumParent Taxa

Other bacteria of the same rank impacting Carnobacterium maltaromaticum

R2SlopeTax NameParent Chart
0.326198637485504150.47262734174728394Blautia obeumParent Taxa
0.29344952106475830.4690445065498352Blautia sp. SC05B48Parent Taxa
0.27450099587440490.6473334431648254Mogibacterium pumilumParent Taxa
0.267789155244827270.4968656003475189Phascolarctobacterium succinatutensParent Taxa
0.260732114315032960.6091381311416626Leuconostoc gasicomitatumParent Taxa
0.26019266247749330.6529619693756104Leuconostoc citreumParent Taxa
0.13041783869266510.3517546057701111Carnobacterium divergensParent Taxa
0.121153451502323150.39749306440353394Lactococcus pisciumParent Taxa

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]